Target Name: MIR1302-1
NCBI ID: G100302227
Review Report on MIR1302-1 Target / Biomarker Content of Review Report on MIR1302-1 Target / Biomarker
MIR1302-1
Other Name(s): microRNA 1302-1 | MicroRNA 1302-1 | hsa-mir-1302-1 | hsa-miR-1302 | MIRN1302-1

MIR1302-1: A Drug Target / Disease Biomarker

MIR1302-1 is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and kidneys. It is a member of the Mir gene family, which encodes a family of transmembrane proteins that play important roles in various cellular processes. One of the main functions of MIR1302-1 is to regulate the levels of glucose in the body.

MIR1302-1 is involved in the glucose signaling pathway, which is a critical pathway that regulates the levels of glucose in the body. This pathway is responsible for maintaining the brain's energy supply, and any imbalances in the levels of glucose in the brain can have serious consequences. MIR1302-1 is involved in the regulation of the glucose transporter GLUT1, which is responsible for transporting glucose into the brain.

In addition to its role in glucose regulation, MIR1302-1 is also involved in the regulation of various other cellular processes. For example, it is involved in the signaling pathway that regulates cell death, and it is also involved in the regulation of cell growth and differentiation.

MIR1302-1 is also of interest as a potential drug target. The MIR1302-1 protein has been shown to be involved in various cellular processes that are important for the development and progression of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

One of the potential ways to target MIR1302-1 is through the use of small molecules that can modulate its activity. For example, researchers have developed a small molecule called rapamycin that can inhibit the activity of MIR1302-1, thereby inhibiting its ability to regulate glucose levels and potentially targeting its role in various diseases.

Another potential way to target MIR1302-1 is through the use of antibodies that can specifically recognize and bind to it. Researchers have developed antibodies that can specifically recognize MIR1302-1 and can be used to block its activity in various cellular processes.

MIR1302-1 is also of interest as a potential biomarker for various diseases. Its involvement in the glucose signaling pathway and its potential as a drug target make it an attractive candidate for use as a biomarker for diseases that are characterized by the disruption of cellular processes that are important for proper cellular function.

In conclusion, MIR1302-1 is a protein that is involved in various cellular processes that are important for the development and progression of various diseases. Its involvement in the glucose signaling pathway and its potential as a drug target make it an attractive candidate for use as a biomarker for diseases that are characterized by the disruption of cellular processes that are important for proper cellular function. Further research is needed to fully understand the role of MIR1302-1 in various cellular processes and its potential as a drug target and biomarker.

Protein Name: MicroRNA 1302-1

The "MIR1302-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1302-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912